Stealth
is a Massachusetts-based biopharmaceutical company that develops and commercializes therapies for the treatment of mitochondrial dysfunctions... Read moreStealth
is a Massachusetts-based biopharmaceutical company that develops and commercializes therapies for the treatment of mitochondrial dysfunctions... Read more
2007
PublicMerged with Stealth Merger Sub LimitedNASDAQMITO
News
May 26, 2026
PR Newswire
Press Release: Stealth : Stealth BioTherapeutics to Present Updates on Elamipretide in Barth Syndrome and POLG Disease at Euromit 2026
Apr 30, 2026
PR Newswire
Press Release: Stealth : Stealth BioTherapeutics Provides Commercial Launch Update and Pipeline Progress Across Mitochondrial Disease Portfolio
Apr 27, 2026
PR Newswire
Press Release: Stealth : Stealth BioTherapeutics to Present Clinical Data for Bevemipretide Eye Drops at the Association for Research in Vision and Ophthalmology 2026 Annual Meeting
Mar 23, 2026
PR Newswire
Press Release: Stealth : Stealth BioTherapeutics Announces MRC Business Engagement Fund Grant to Advance Mitochondrial Disease Research
Jan 06, 2026
PR Newswire
Press Release: Stealth : Stealth BioTherapeutics Provides Commercial and R&D Pipeline Update and Outlines 2026 Strategic Priorities
Oct 09, 2025
Yahoo
Stealth: Stealth BioTherapeutics Announces Mito Assist Patient Support Program and Specialty Pharmacy Partnership with AnovoRx to Distribute FORZINITY (elamipretide) injection
Sep 23, 2025
Pharmabiz
Stealth: US FDA grants accelerated approval to Stealth Bio's Forzinity to improve muscle strength in adult and paediatric patients with Barth syndrome
Sep 16, 2025
BioSpace
Stealth: Stealth, Barth Community Await FDA Verdict With 'Everything at Stake'
Aug 26, 2025
BioPharma Dive
Stealth: Why an FDA decision on Stealth's Barth drug could ripple through the rare disease field
Aug 05, 2025
STAT News
Stealth: STAT+: After 'conflicting' signals from FDA, rare disease drugmaker contemplates closure
Stealth Competitors
1
2
3
4
5
6
7
8
9
10